Our data reveal anti-Gr1-, but not anti-Ly6G-treatment significantly reduces the production of TGF-β and TNF-α in the hearts of mice (Figure 6A), therefore leading to less collagen deposition and reduced cardiac fibrosis on day 21 after infection. This evidence concerns the gene TGFB1 and infection.